Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,838
Total Claims
$936K
Drug Cost
264
Beneficiaries
$3,546
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-95%
Opioid rate vs peers
0.1% vs 2.2% avg
+151%
Cost per patient vs peers
$3,546 vs $1,411 avg
+33%
Brand preference vs peers
14.1% vs 10.6% avg
Opioid Prescribing
0.1%
Opioid Rate
12
Opioid Claims
$65
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,510 claims · $631K
Generic: 9,171 claims · $299K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 76 | $81K |
| Apixaban | 195 | $72K |
| Rufinamide | 18 | $71K |
| Dulaglutide | 42 | $39K |
| Rivaroxaban | 83 | $38K |
| Dextromethorphan Hbr/Quinidine | 27 | $21K |
| Sacubitril/Valsartan | 52 | $20K |
| Insulin Aspart | 32 | $14K |
| Empagliflozin | 15 | $14K |
| Ticagrelor | 20 | $12K |
| Memantine Hcl | 127 | $12K |
| Divalproex Sodium | 78 | $12K |
| Insulin Detemir | 34 | $11K |
| Midodrine Hcl | 111 | $11K |
| Erythromycin Base | 12 | $10K |
Prescribing Profile
Patient Profile
72
Avg Age
53%
Female
1.47
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data